Picture of LAVA Therapeutics NV logo

LVTX — LAVA Therapeutics NV News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: LAVA Therapeutics Provides Business Update, Reports Third Quarter Financial Results

Nov 16 (Reuters) - LAVA Therapeutics NV  LVTX.O :
    * LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS
THIRD
QUARTER FINANCIAL RESULTS
    * LAVA THERAPEUTICS NV Q3 EARNINGS PER SHARE $0.04
    * LAVA THERAPEUTICS- CASH &INVESTMENTS OF $92.7 MILLION AS
OF
SEPTEMBER 30, PLUS$50.0 MILLION RECEIVED FROM SEAGEN IN OCT
PROVIDE CASH RUNWAY BEYOND 2024
    * LAVA THERAPEUTICS NV - QTRLY RESEARCH AND LICENSE REVENUE
$15.3
MILLION

Source text for Eikon:  ID:nGNX2GNL0n 
Further company coverage:  LVTX.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on LAVA Therapeutics NV

See all news